331 related articles for article (PubMed ID: 35074140)
1. Adherence to Isoniazid Preventive Therapy among children living with tuberculosis patients in Delhi, India: An exploratory prospective study.
Sharma N; Basu S; Khanna A; Sharma P; Chopra KK; Chandra S
Indian J Tuberc; 2022 Jan; 69(1):100-103. PubMed ID: 35074140
[TBL] [Abstract][Full Text] [Related]
2. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
3. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy?
Shivaramakrishna HR; Frederick A; Shazia A; Murali L; Satyanarayana S; Nair SA; Kumar AM; Moonan PK
Int J Tuberc Lung Dis; 2014 Aug; 18(8):919-24. PubMed ID: 25199005
[TBL] [Abstract][Full Text] [Related]
5. To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India.
Reddy MM; Thekkur P; Ramya N; Kamath PBT; Shastri SG; Kumar RBN; Chinnakali P; Nirgude AS; Rangaraju C; Somashekar N; Kumar AMV
Glob Health Action; 2020; 13(1):1704540. PubMed ID: 31937200
[No Abstract] [Full Text] [Related]
6. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
Nyathi S; Dlodlo RA; Satyanarayana S; Takarinda KC; Tweya H; Hove S; Matambo R; Mandewo W; Nyathi K; Sibanda E; Harries AD
PLoS One; 2019; 14(10):e0223076. PubMed ID: 31581271
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C
PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300
[TBL] [Abstract][Full Text] [Related]
9. Adherence to and outcome of isoniazid chemoprophylaxis among household contact children of adults having pulmonary tuberculosis in Alexandria, Egypt.
Mohamed AM
J Egypt Public Health Assoc; 2012 Aug; 87(3-4):71-8. PubMed ID: 22936243
[TBL] [Abstract][Full Text] [Related]
10. Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study.
Okwara FN; Oyore JP; Were FN; Gwer S
BMC Infect Dis; 2017 Sep; 17(1):623. PubMed ID: 28915796
[TBL] [Abstract][Full Text] [Related]
11. Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study.
Dhungana GP; Thekkur P; Chinnakali P; Bhatta U; Pandey B; Zhang WH
BMJ Open; 2019 May; 9(5):e029058. PubMed ID: 31147370
[TBL] [Abstract][Full Text] [Related]
12. Implementation of isoniazid preventive therapy in southern Lima, Peru: an analysis of health center characteristics.
Zegarra-Chapoñan R; Bonadonna LV; Yuen CM; Martina-Chávez MB; Zeladita-Huaman J
Infect Dis Poverty; 2021 May; 10(1):63. PubMed ID: 33962691
[TBL] [Abstract][Full Text] [Related]
13. Implementation of tuberculosis preventive therapy with INH-Rifapentine (3HP) for latent tuberculosis infection management in household tuberculosis contacts in India: A prospective study.
Sharma N; Bakshi R; Basu S; Zode M; Arora R; Khanna A
Trop Med Int Health; 2023 Dec; 28(12):890-900. PubMed ID: 37864386
[TBL] [Abstract][Full Text] [Related]
14. Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
Page-Shipp L; Lewis JJ; Velen K; Senoge S; Zishiri E; Popane F; Chihota VN; Clark D; Churchyard GJ; Charalambous S
PLoS One; 2018; 13(3):e0192089. PubMed ID: 29499060
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting.
Padmapriyadarsini C; Sekar L; Reddy D; Chitra A; Poornagangadevi N; Selvaraj M; Bhavani PK; Mothi SN; Nandagopal K; Vennila S; Tamizhselvan M; Maheshmanisha J; Agarwal U; Rewari BB; Swaminathan S
Indian J Med Res; 2020 Dec; 152(6):648-655. PubMed ID: 34145105
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid preventive therapy among child contacts of TB patients, India.
Ghoshal Mukherjee A; Das DK; De S; Banerjee N
Int J Tuberc Lung Dis; 2022 Jul; 26(7):650-657. PubMed ID: 35768913
[No Abstract] [Full Text] [Related]
17. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
[TBL] [Abstract][Full Text] [Related]
18. Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis.
Zelner JL; Murray MB; Becerra MC; Galea J; Lecca L; Calderon R; Yataco R; Contreras C; Zhang Z; Grenfell BT; Cohen T
Am J Respir Crit Care Med; 2014 Apr; 189(7):853-9. PubMed ID: 24592878
[TBL] [Abstract][Full Text] [Related]
19. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
[TBL] [Abstract][Full Text] [Related]
20. Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients.
Belgaumkar V; Chandanwale A; Valvi C; Pardeshi G; Lokhande R; Kadam D; Joshi S; Gupte N; Jain D; Dhumal G; Deluca A; Golub J; Gupta A; Kinikar A; Bollinger RC
Int J Tuberc Lung Dis; 2018 Oct; 22(10):1179-1187. PubMed ID: 30236186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
